Germline and Somatic Genetic Changes in Pulmonary Arterial Hypertension
Germline and Somatic Genetic Changes in Pulmonary Arterial Hypertension
批准号:
8051644
负责人:
Micheala A Aldred
金额:
$39.25万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-01 至 2014-03-31
关键词:
ACVRL1 geneAbnormal CellAddressAffectAllelesAlternative SplicingBMPR2 geneBlood VesselsCancer ModelCell ProliferationCessation of lifeChromosome SegregationChromosome abnormalityChromosomesComplexCytoskeletal ProteinsDNADNA MethylationDataDevelopmentDiseaseDisease susceptibilityEnvironmental Risk FactorEpigenetic ProcessEtiologyEventExhibitsExonsGene Expression RegulationGenesGeneticGenetic ModelsGenetic PolymorphismGenomic InstabilityGerm-Line MutationGoalsHeart failureHypoxiaIndividualInflammationInheritedKnowledgeLIMK1 geneLeadLesionLifeLinkLungLung diseasesMalignant NeoplasmsMediator of activation proteinMessenger RNAMethylationMitosisMitoticMutationNeoplasmsNeoplastic ProcessesNumerical Chromosomal AbnormalityOther GeneticsPathogenesisPathway interactionsPatientsPenetrancePlayPopulation ControlPredispositionProgressive DiseasePulmonary HypertensionPulmonary artery structureRNA SplicingReactive Oxygen SpeciesRecurrenceRiskRoleSignal TransductionSmooth Muscle MyocytesSomatic MutationStructure of parenchyma of lungTechniquesTestingTextTherapeutic InterventionUntranslated RegionsVariantWorkarteriolebone morphogenetic protein receptor type IIbone morphogenetic protein receptorscofilincyclin D2disease phenotypedisorder preventiondynein light chainmRNA Stabilitymutation carriernoveloverexpressionpressurepreventpublic health relevancepulmonary arterial hypertensionpulmonary artery endothelial celltherapeutic targettoolvasoconstriction
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Pulmonary arterial hypertension (PAH) is a serious lung disease characterized by progressive narrowing of the small pulmonary arteries and elevated pulmonary artery pressure, which can lead to right heart failure. Mutations of the BMPR2 gene are identifiable in about 75% of familial PAH cases and 20-25% of sporadic idiopathic cases. However, the penetrance of these mutations is low and the additional genetic or environmental factors that contribute to the etiology of PAH are not well understood. There is some prior evidence that proliferative lesions in the lung are akin to neoplasia, with monoclonal expansion and genetic instability. Extending this analogy with cancer, we hypothesize that genetic or epigenetic mutations are present in PAH lung tissues and contribute to the development or progression of PAH through abnormal cell proliferation and signaling. The aims of the study are: (1) to characterize the role of somatic genetic and epigenetic changes in PAH lungs; (2) to investigate the mechanisms that could predispose to genomic instability; and (3) to test the hypothesis that intragenic polymorphisms modify susceptibility to PAH by affecting expression of BMPR2 in the lung. The overall goals are to understand reduced penetrance in familial PAH, to determine to what extent BMPR2 plays a role in PAH cases with no detectable germline mutation and to begin investigating other (epi)genetic events that may offer common pathogenic links between different types of PAH.
PUBLIC HEALTH RELEVANCE: Pulmonary arterial hypertension is a serious, potentially life-threatening lung disorder with a complex etiology. This study seeks to characterize inherited and acquired genetic changes that contribute to the pathogenesis of pulmonary hypertension. The long term aims are to better understand what causes pulmonary hypertension and who is most at risk, in order to refine therapeutic interventions and work towards prevention of the disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genomics of Pulmonary Vascular Disease
-
批准号:10493617
-
项目类别:
-
资助金额:$2.44万
-
财政年份:2022
-
负责人:Micheala A Aldred
-
依托单位:
Genomics of Pulmonary Vascular Disease
-
批准号:10591773
-
项目类别:
-
资助金额:$6.86万
-
财政年份:2018
-
负责人:Micheala A Aldred
-
依托单位:
Genomics of Pulmonary Vascular Disease
-
批准号:10593913
-
项目类别:
-
资助金额:$85.45万
-
财政年份:2018
-
负责人:Micheala A Aldred
-
依托单位:
Genomics of Pulmonary Vascular Disease
-
批准号:9893020
-
项目类别:
-
资助金额:$77.72万
-
财政年份:2018
-
负责人:Micheala A Aldred
-
依托单位:
Genomics of Pulmonary Vascular Disease
-
批准号:10382380
-
项目类别:
-
资助金额:$77.69万
-
财政年份:2018
-
负责人:Micheala A Aldred
-
依托单位:
Genomics of Pulmonary Vascular Disease
-
批准号:10820195
-
项目类别:
-
资助金额:$6.86万
-
财政年份:2018
-
负责人:Micheala A Aldred
-
依托单位:
Nonsense Readthrough: a Therapeutic Approach to Inherited Vascular Disorders
-
批准号:9616979
-
项目类别:
-
资助金额:$20.95万
-
财政年份:2016
-
负责人:Micheala A Aldred
-
依托单位:
Pulmonary Hypertension Breakthrough Initiative
-
批准号:9307972
-
项目类别:
-
资助金额:$250.73万
-
财政年份:2015
-
负责人:Micheala A Aldred
-
依托单位:
Role of the X-chromosome in Pulmonary Arterial Hypertension
-
批准号:8211964
-
项目类别:
-
资助金额:$7.85万
-
财政年份:2011
-
负责人:Micheala A Aldred
-
依托单位:
Role of the X-chromosome in Pulmonary Arterial Hypertension
-
批准号:8335477
-
项目类别:
-
资助金额:$7.85万
-
财政年份:2011
-
负责人:Micheala A Aldred
-
依托单位:
Germline and Somatic Genetic Changes in Pulmonary Arterial Hypertension
-
批准号:8446404
-
项目类别:
-
资助金额:$36.99万
-
财政年份:2010
-
负责人:Micheala A Aldred
-
依托单位:
Germline and Somatic Genetic Changes in Pulmonary Arterial Hypertension
-
批准号:9619824
-
项目类别:
-
资助金额:$19.22万
-
财政年份:2010
-
负责人:Micheala A Aldred
-
依托单位:
Germline and Somatic Genetic Changes in Pulmonary Arterial Hypertension
-
批准号:7896244
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2010
-
负责人:Micheala A Aldred
-
依托单位:
Germline and Somatic Genetic Changes in Pulmonary Arterial Hypertension
-
批准号:8236863
-
项目类别:
-
资助金额:$38.86万
-
财政年份:2010
-
负责人:Micheala A Aldred
-
依托单位:
海外基金